For research use only. Not for therapeutic Use.
6α,3’-p-Dihydroxy Paclitaxel is a derivative of the anticancer drug paclitaxel, used in pharmaceutical and biochemical research. Known for its potential therapeutic properties, it is essential for studying the pharmacokinetics, pharmacodynamics, and metabolic pathways of paclitaxel analogs. This compound aids in understanding the mechanisms of action, optimizing drug efficacy, and reducing side effects. Researchers rely on 6α,3’-p-Dihydroxy Paclitaxel for precise and reliable results in advanced oncology research and drug development, contributing significantly to innovations in cancer treatment.
Catalog Number | R011693 |
CAS Number | 157230-10-9 |
Synonyms | (αR,βS)-β-(Benzoylamino)-α,4-dihydroxybenzenepropanoic Acid 6,12b-Bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-3,4,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl Ester; |
Molecular Formula | C47H51NO16 |
Purity | ≥95% |
Storage | -20°C |
InChI | InChI=1S/C47H51NO16/c1-23-30(62-43(58)33(52)32(26-17-19-29(51)20-18-26)48-41(56)27-13-9-7-10-14-27)21-47(59)40(63-42(57)28-15-11-8-12-16-28)36-45(6,38(55)35(61-24(2)49)31(23)44(47,4)5)37(54)34(53)39-46(36,22-60-39)64-25(3)50/h7-20,30,32-37,39-40,51-54,59H,21-22H2,1-6H3,(H,48,56)/t30-,32-,33+,34-,35+,36-,37-,39+,40-,45-,46+,47+/m0/s1 |
InChIKey | NEGGNAWLXHJUEM-FJMWQILYSA-N |
SMILES | CC1=C2C(C(=O)C3(C(C(C(C2(C)C)(CC1OC(=O)C(C(C4=CC=C(C=C4)O)NC(=O)C5=CC=CC=C5)O)O)OC(=O)C6=CC=CC=C6)C7(COC7C(C3O)O)OC(=O)C)C)OC(=O)C |